| 1. Dr. Shalini Mehta on “SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP OF NEW ARYL AND HETEROARYL SEMICARBAZONES AS ANTICONVULSANTS”- Completed in 2007. (Current position: Works at FDA & F. Hoffmann La Roche AG, USA) 2. Dr. J.Vaigunda Raghavendran on "DESIGN OF GABA ANALOGUES AS ANTICONVULSANTS - SYNTHESIS & NEUROPHARMACOLOGY"- Completed in 2008. (Current position: Scientific Medical Writer, Ogilvy CommonHealth Worldwide, Montreal, Canada) 3. Dr. A.S.K. Reddy on "SYNTHESIS AND NEUROPHARMACOLOGY OF 4-AMINOBUTYRIC ACID ANALOGUES"- Completed in 2009. (Current position: Scientist at Aurobindo Pharma, Hyderabad, India) 4. Dr. Arvind Semwal on "PHARMACOLOGICAL INTERVENTIONS TO IDENTIFY POTENTIAL DRUG CANDIDATES FOR THE TREATMENT OF NEUROPATHIC PAIN"- Completed in 2012 (Current position: senior Manager, Medical Writing, Parexel International, Hyderabad, India) 5. Dr. Pritesh Bhat on “DESIGN OF VARIOUS NEW ENZYME INHIBITORS AS ANTIMYCOBACTERIAL AGENTS USING IN-SILICO HIGH-THROUGHPUT SCREENING"- Completed in 2013. (Current position: Senior Applications Scientist at Schrodinger, Bangalore, India) 6. Dr. Monika Sharma on "DESIGN AND SYNTHESIS OF MULTIFUNCTIONAL LEADS FOR THE TREATMENT OF NEUROPATHIC PAIN"- Completed in 2013. (Current position: Postdoctoral Fellow, Nanyang Technical Universty (NTU), Singapore) 7. Dr. J.T. Patrisha on "PHARMACOPHORE MODELING AND 3D QSAR COMBINED WITH VIRTUAL SCREENING TO IDENTIFY NOVEL INHIBITORS OF PROTEIN TARGETS OF INFECTIOUS DISEASES"-Completed in 2015. (Current position: Entrepreneur, Trinity Groups, India) 8. Dr. Madhu Babu B on "DESIGN, SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NOVEL CATHEPSIN S INHIBITORS"- Completed in 2015. (Current position: Entrepreneur- Started a Diagnostic Centre)
9. Dr. Saketh Sriram on "STRUCTURE-BASED DESIGN AND SYNTHESIS OF NOVEL AKT INHIBITORS FOR PRECLINICAL EVALUATION IN LUNG CANCER CELL LINES"-Completed in 2015.(Current position: PostDoc, Penn State College of Medicine, Hershey, PA) 10. Dr. P. Brindha Devi on "DEVELOPMENT OF NOVEL PANTOTHENATE SYNTHETASE AND LYSINE AMINOTRANSFERASE INHIBITORS AGAINST ACTIVE AND DORMANT TUBERCULOSIS"- Completed in 2015.(Current position: Assistant Professor, Department of Bio-Engineering, Vels Institute of Science, Technology and Advanced Studies, Chennai, India) 11. Dr. Ram Kumar Mishra on "DESIGN AND CHARACTERIZATION OF NOVEL PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF NEURONAL COMPLICATIONS OF DIABETES"- Completed in 2015. (Current position: Project Analyst, ICON PLC, Bangalore, India) 12. Dr. Reshma Chowdhary on "DUAL INHIBITORS OF ROCK-I AND NOX2 TO ATTENUATE NEUROINFLAMMATION IN NEUROLOGICAL DISORDERS: HIGH THROUGHPUT VIRTUAL ND BIOLOGICAL SCREENING"- Completed in 2015. (Current position: Research Associate, Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India) 13. Dr. Venkat Koushik (CSIR SRF) on "TARGETING SIRT1 AND ITS PATHWAY FOR THERAPEUTIC INTERVENTION OF CANCER: DRUG DESIGN AND BIOLOGICAL EVALUATION"- Completed in March 2016 (Current position: Senior Product Manager, Merck Group Bangalore, India) 14. Dr. Brahmam Medapi (ICMR SRF) on DEVELOPMENT OF NOVEL QUINOLINE ANALOGUES AS MYCOBACTERIUM TUBERCULOSIS DNA GYRASE INHIBITORS- Completed in June 2016. (Current Position: Associate Scientist, GVKBio, Bangalore, India)
15. Dr. Priyanka S on "COMPUTATIONAL ANALYSES OF MYCOBACTERIUM TUBERCULOSIS ENZYME INHIBITORS: A STUDY INVOLVING FREE ENERGY PERTURBATION AND MOLECULAR DYNAMICS SIMULATIONS"-Completed in Dec 2016. (Current Position: Post Doctoral Scientist, University of Kentucky) 16. Dr. Srikant Racharla on DESIGN, SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF NOVEL ADENOSINE A2 MODULATORS FOR TREATMENT OF EPILEPSY AND PAIN- Completed in September 2016. (Current Position: Research Associate, Hospira, Pfizer company, Chennai) 17. Dr. Hasitha S Anantharaju (DST INSPIRE Fellow) on CATHEPSIN D, AN ASPARTATE PROTEASE AS A POTENT THERAPEUTIC OPTION FOR BREAST CANCER: DESIGN, SYNTHESIS AND BIOEVALUATION AGAINST TRIPLE POSITIVE AND TRIPLE NEGATIVE BREAST CANCERS- Completed in October 2017. (Current Position: Scientific Writer II, Novartis, Hyderabad, India) 18. Dr. M. Gangadhar on "MOLECULAR PHARMACOLOGICAL INVESTIGATIONS ON NEW CHEMICAL ENTITIES USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN - Completed in Feb 2018 (Current Position: Senior Research Associate, GVK EXCELRA, Hyderabad) 19. Dr. Pushkar Kulkarni (ILS, Hyderabad) on "ZEBRA FISH MODELS FOR NEUROSCIENCE DRUG DISCOVERY -Completed in June 2018 (Current Position: Dr. Reddy's Institute of Life Sciences, University of Hyderabad campus, Hyderabad) 20. Mr. Shubham Diwedi (DBT JRF, BITS Scholar, ICMR SRF) on DEVELOPMENT, VALIDATION, AND EXPLORATION OF NOVEL DISEASE MODELS FOR AUTISM, Completed in December 2019 Current Position: Assistant Professor, University of Petroleum and Energy Studies, Uttarkhand ) 21. Mr. Parameshwar Reddy (AMRI, Hyderabad) on SYNTHESIS OF NOVEL LEADS USEFUL FOR NEUROLOGICAL DISEASES, Completed in September 2021
|